Skip to main content

Find Clinical Trials

Home
Conditions
CD19+ Malignancies: Relapse Post-allogeneic Transplant

Clinical trial condition

CD19+ Malignancies: Relapse Post-allogeneic Transplant

Explore clinical trials studying CD19+ Malignancies: Relapse Post-allogeneic Transplant. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

CD19+ Malignancies: Relapse Post-allogeneic Transplant trial results

Completed

CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic Transplantation

NCT02893189

Conditions: CD19+ Malignancies: Relapse Post-allogeneic Transplant, Disease Attributes, Pathologic Processes, +2 more
Locations: University College London Hospital London, United Kingdom

View Trial Details